Filing Flows › Nutex Health (NUTX) › Q4 2025
Nutex Health (NUTX) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 5, 2026
Nutex Health (NUTX) reported revenue of $152M for the fourth quarter 2025 (Q4 2025), -41% from a year earlier and -43% from the quarter before. Operating margin was 20.4%, net earnings $11.8M (7.8% of revenue).
Nutex Health, Q4 2025: revenue $152M (-41% year over year), operating margin 20.4%, net earnings $11.8M, operating cash flow $70.4M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $152M | -43% | -41% |
| Gross profit | $46.1M | -70% | -67% |
| Operating profit | $30.9M | -76% | -73% |
| Net earnings | $11.8M | -79% | -81% |
| Operating cash flow | $70.4M | -29% | 1,304× |
| Free cash flow | $69.0M | -30% | — |
What changed
Revenue was $151.7M in Q4 2025, down 41% year over year and down 43% from the previous quarter. Hospital division was the largest line at 95% of revenue.
Gross margin was 30.4%, down 24.6 points from a year earlier. Operating profit was $30.9M, a 20.4% margin (down 23.9 points year over year). Operating expenses fell 44% while revenue fell 41%. Net earnings were $11.8M, down 81% year over year. The effective tax rate was 35.9%.
Operating cash flow was $70.4M (up 130250% year over year), 424% of net income including minority interests. Non-cash charges added back $5.2M of depreciation and amortization. Working capital and other items added $48.6M. Capital expenditures of $1.4M left free cash flow of $69.0M.
Questions
What was Nutex Health's revenue in the fourth quarter 2025?
Nutex Health (NUTX) reported revenue of $152M for the fourth quarter 2025 (Q4 2025), -41% from a year earlier and -43% from the quarter before.
Was Nutex Health profitable in the fourth quarter 2025?
Operating profit was $30.9M (20.4% of revenue) and net earnings $11.8M.
Source: Nutex Health 10-K on SEC EDGAR.